DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCorporate Action

Bliss GVS Pharma Limited — Resignation of Director/KMP/SMP

NSE 1 hr ago·24 Jul 2026, 2:22 pm

Bliss GVS Pharma

Bliss GVS Pharma Limited has announced the resignation of a Director, Key Managerial Personnel (KMP), or Senior Managerial Personnel (SMP). The company has submitted this information to the stock exchanges as per regulatory requirements.

For investors, this news is a routine corporate update. While a change in leadership can sometimes indicate internal shifts, it does not necessarily reflect the company's financial health or future performance. It is important to focus on the company's operational metrics rather than personnel changes.

Investors should monitor the company's future disclosures for any context regarding the resignation. Until more information is available, there is no immediate cause for concern regarding the stock's fundamentals.